<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Prostate Cancer Tumor Homografts for I/O Assessment

New preclinical models are needed for prostate cancer drug development, which can be used to assess combination regimens of immunotherapies alongside chemotherapy and targeted agents.